行情

DARE

DARE

Dare Bioscience
NASDAQ

实时行情|Nasdaq Last Sale

0.8424
-0.0076
-0.89%
已收盘, 16:00 04/03 EDT
开盘
0.8700
昨收
0.8500
最高
0.8845
最低
0.8250
成交量
5.43万
成交额
--
52周最高
2.220
52周最低
0.6902
市值
2,079.92万
市盈率(TTM)
-0.8602
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测DARE价格均价为3.750,最高价位5.00,最低价为3.000。

EPS

DARE 新闻

更多
  • 为美元续命,美联储干了这件大事!
  • 新浪财经-自媒体综合 · 52分钟前
  • 债务危机幽灵再现,激进放水后美联储或只剩一个策略
  • 新浪财经综合 · 57分钟前
  • 德国今年经济或因疫情萎缩3-6%
  • 新浪财经 · 1小时前
  • 土豪国也撑不住:迪拜最大地产公司全员减薪
  • 新浪财经 · 1小时前

所属板块

生物技术和医学研究
-0.50%
制药与医学研究
-0.22%

热门股票

代码
价格
涨跌幅

DARE 简况

Dare Bioscience, Inc., formerly Cerulean Pharma Inc., is a healthcare company. The Company is focused on the development and commercialization of products in women’s reproductive health. Its lead product candidate is Ovaprene, a clinical stage, non-hormonal contraceptive ring. The Company is developing Ovaprene to provide protection over multiple weeks of use and require no intervention at the time of intercourse. Ovaprene has a custom intravaginal ring design, with a permeable mesh in the center of the ring that creates a partial barrier to sperm, and a mechanism to release locally acting spermiostatic agents through the ring. The combination of these two complementary approaches produces attractive contraceptive efficacy outcomes that are consistent with the effective barrier option, the diaphragm, and short-acting hormonal options, such as oral pill, patches and vaginal ring.
展开

微牛提供Dare Bioscience Inc(NASDAQ-DARE)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的DARE股票新闻,以帮助您做出投资决策。